Skip to content
  • Patients and general enquiries
  • Practitioner log-in portal
  • Powered by Inventiva CS

OtogenexOtogenex
  • Home
  • Information for Patients and Family
    • General
      • How we work
      • Find a doctor near you
      • Privacy and data protection
      • Payments
      • Health insurance and rebates
      • Genetic counselling
      • FAQs
    • Our Technology
      • Exome sequencing
      • Medical grade resolution
      • Custom database combined with AI technologies
      • Secure reports assessed by licensed experts
    • Patient Medical Reports
      • Meniere’s and hydropic inner ear disease
      • Syndromic hearing loss
      • Non syndromic hearing loss
      • Hearing loss susceptibility – toxic and cancer drugs
      • Migraine associated vertigo
      • Vestibular rehabilitation clinics
      • Researchers and clinical trials
      • Candidate screening for future hearing loss technologies
  • Information for Medical Practitioners
    • Clinical Solutions
      • Audiologists
      • Cochlear implant services
      • Indigenous health providers
      • Medical insurance claims
      • ENT, otology and neuroscience medical practices
      • Occupational audio health
      • Otolaryngologists
      • Otoneurologists
      • Treatment pathways
      • University clinics
    • General
      • Practitioners – contact us
      • Practitioner login-in portal
  • Sample Reports
  • Pipeline Treatments
  • About Us
    • Our story
    • Our team
    • Our experts
    • Our facilities
    • Accreditations, qualifications and licensing
    • Terms & conditions
    • Regulatory statements
    • International standards
    • Investors
    • Accessibility statement
  • Our Policies
    • Privacy policy
    • Data protection policy
    • Cookies policy
    • Accessibility policy
    • Intellectual property policy
    • Terms of use
  • Contact Us
    • Practitioners only
    • Patients only

In association with

Otogenix Genomic driven Otology Barany Society
Otogenix Genomic driven Otology Passee And Williams Foundation
Otogenix Genomic driven Otology Nsw Health
Otogenix Genomic driven Otology Nhs Cambridge Univesity Hospital
Otogenix Genomic driven Otology John Hopkins
Otogenix Genomic driven Otology Harvard Medical School

Proactive, prevention and carrier

Otolaryngology care is primarily reactive, addressing hearing and balance disorders as they present. Otogenix, on the other hand, allows for a forward-looking approach. By identifying genetic predispositions, patients and doctors to can anticipate potential hearing challenges, paving the way for early interventions and preventive measures tailored to one's unique genetic make up.

Informed, personalised treatment

Conventional treatments is often one-size-fits-all, but Otogenix reports can pave the way for precision, personal treatments. By understanding individual genetic susceptibility, treatments can be tailored to target specific conditions and challenges. This ensures not only greater efficacy but also minimises potential side effects or inefficiencies tied to generalised interventions.

Advanced genetic insights

Traditional methods, while invaluable, are limited to the knowledge and technology of their time. OtoGenie leverages a vast, continually updated database, brimming with the latest scientific research on genetics and hearing health. This ensures that our diagnostics are not only grounded in the present but also attuned to the cutting-edge advancements in the field, offering a depth and breadth of understanding unparalleled by conventional means.

Precision diagnostic tools

While traditional methods often provide a broad overview based on symptoms and general assessments, OtoGenie delves into the intricate details of your genetic makeup. Our DNA-driven approach ensures pinpoint accuracy, targeting the very genetic markers and variants that influence hearing health. This precision reduces ambiguities and offers a clearer, more comprehensive diagnostic picture.

OtogenexOtogenex

OtoGenie harnesses advanced DNA diagnostics to provide unparalleled insights into hearing health, revolutionising otolaryngologic care.

Leave us a message

Telephone

TBA

Location

77 Castlereagh St, Sydney NSW 2000

Email

info@otogenie.com

For Patients

General

How it works
Find a provider
Privacy and data protection
Payments
Health insurance and rebates
Genetic counselling
FAQ’s
Patient contact us form

Our Technology

Exome sequencing
Medical grade resolution
Custom database combined with AI
Secure reports assessed by licensed experts

Patient Medical Reports

Syndromic hearing loss
Non syndromic hearing loss
Meniere’s and hydropic inner ear disease
Hearing loss susceptibility - toxic and cancer drugs
Vestibular rehabilitation clinics
Researchers and clinical trials
Candidate screening for future hearing loss technologies

About

Home
About us
Our story
Our experts
Our facilities
Accreditations, qualifications and licensing
Terms & conditions
Regulatory statements
International standards
Investor and employment
Accessibility statement
Contact us (Patients and general enquiries)

For Practitioners

Audiologists
Cochlear implant services
Indigenous health providers
Medical insurance claims
ENT, otology and neuroscience medical practices
Occupational audio health
Otolaryngologists
Otoneurologists
Treatment pathways
University clinics
Medical practitioner log-in portal
Contact us (Practitioners)

Our Policies

Privacy policy
Data protection policy
Cookies policy
Accessibility policy
Intellectual property policy
Terms of use

Corporate governance &regulation

Regional
Patents and IP
Copyright 2023 | Otogenex Pty. Limited ACN: ######## | Otogenex acknowledges traditional owners of country throughout Australia and recognises the continuing connection to lands, waters and communities. We pay our respect to Aboriginal and Torres Strait Islander cultures and to Elders past and present.
  • Home
  • Information for Patients and Family
    • General
      • How we work
      • Find a doctor near you
      • Privacy and data protection
      • Payments
      • Health insurance and rebates
      • Genetic counselling
      • FAQs
    • Our Technology
      • Exome sequencing
      • Medical grade resolution
      • Custom database combined with AI technologies
      • Secure reports assessed by licensed experts
    • Patient Medical Reports
      • Meniere’s and hydropic inner ear disease
      • Syndromic hearing loss
      • Non syndromic hearing loss
      • Hearing loss susceptibility – toxic and cancer drugs
      • Migraine associated vertigo
      • Vestibular rehabilitation clinics
      • Researchers and clinical trials
      • Candidate screening for future hearing loss technologies
  • Information for Medical Practitioners
    • Clinical Solutions
      • Audiologists
      • Cochlear implant services
      • Indigenous health providers
      • Medical insurance claims
      • ENT, otology and neuroscience medical practices
      • Occupational audio health
      • Otolaryngologists
      • Otoneurologists
      • Treatment pathways
      • University clinics
    • General
      • Practitioners – contact us
      • Practitioner login-in portal
  • Sample Reports
  • Pipeline Treatments
  • About Us
    • Our story
    • Our team
    • Our experts
    • Our facilities
    • Accreditations, qualifications and licensing
    • Terms & conditions
    • Regulatory statements
    • International standards
    • Investors
    • Accessibility statement
  • Our Policies
    • Privacy policy
    • Data protection policy
    • Cookies policy
    • Accessibility policy
    • Intellectual property policy
    • Terms of use
  • Contact Us
    • Practitioners only
    • Patients only
  • Patients and general enquiries